Show simple item record

dc.contributor.authorRodriguez-Morales, A.J.
dc.contributor.authorSah, R.
dc.contributor.authorMillan-Oñate, J.
dc.contributor.authorGonzalez, A.
dc.contributor.authorMontenegro-Idrogo, J.J.
dc.contributor.authorScherger, S.
dc.contributor.authorFranco-Paredes, C.
dc.contributor.authorHenao-Martínez, A.F.
dc.date.accessioned2025-10-31T18:32:32Z
dc.date.available2025-10-31T18:32:32Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4684
dc.description.abstractInvasive mycoses represent opportunistic infections occurring predominantly among highly immunosuppressed individuals, including those with advanced human immunodeficiency virus-associated immunosuppression, uncontrolled diabetes mellitus, drug-induced immunosuppression during transplantation, autoimmune disorders, or hematological malignancies. The overuse of high-dose glucocorticoids and the administration of highly immunosuppressive drugs such as inhibitors of the Janus kinase inhibitors or IL-6 receptor inhibitors to treat patients with the coronavirus disease 2019 (COVID-19) are responsible in part for the increasing number of life-threatening opportunistic infections identified in this patient population...en_US
dc.description.sponsorshipWe dedicate this Editorial to the memory of Dr. Francisco Miguel Marty, who died tragically in 2021. Dr. Marty is remembered as a gentle, well-rounded individual with extensive expertise in mucormycosis and other opportunistic infections, including mucormycosis in organ transplant recipients and patients with malignancies. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherGE Publications
dc.relation.ispartofurn:issn:2049-937X
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectInvasive Fungal Infections and Antifungal Resistanceen_US
dc.subjectMucormycosis: Emerging Fungal Infections and Treatmentsen_US
dc.titleCOVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugsen_US
dc.typehttps://purl.org/coar/resource_type/c_b239
dc.identifier.doihttps://doi.org/10.1177/20499361211027065
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.05
dc.type.otherEditorial
dc.identifier.journalTherapeutic Advances in Infectious Disease
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2